We investigated BCR-ABL kinase domain mutations in CD34+ cells from 100 chronic-phase CML patients by multiplex allele-specific PCR and sequencing at diagnosis. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.